Free Trial

Electromed Q2 2024 Earnings Report

Electromed logo
$29.58 +0.93 (+3.25%)
(As of 01:10 PM ET)

Electromed EPS Results

Actual EPS
$0.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Electromed Revenue Results

Actual Revenue
$13.69 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Electromed Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

Click here to check it out now

Electromed Earnings Headlines

Forced out of retirement by these trades
You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed
Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript
The Stocks Our Experts Are Trading Now
See More Electromed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Electromed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Electromed and other key companies, straight to your email.

About Electromed

Electromed (NYSE:ELMD) develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

View Electromed Profile

More Earnings Resources from MarketBeat